April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
July 2025
The U.S. mRNA therapeutics market size was estimated at USD 5.48 billion in 2025 and is projected to hit USD 12.70 billion by 2036, with a notable CAGR of 8.77%
July 2026
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
August 2026
The global targeted therapeutics market size was estimated at USD 85.75 billion in 2025 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
July 2026
The pain management therapeutics market size accounted for USD 88.19 billion in 2025 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
July 2026
The global alkaptonuria therapeutics market size is estimated at USD 16.19 million in 2025 and is expected to hit around USD 32.27 million by 2035, growing at a CAGR of 7.14%.
July 2026
The global digital therapeutics market size was exhibited at USD 9.73 billion in 2025 and is projected to surpass around USD 65.31 billion by 2035, with a remarkable CAGR of 20.97%.
July 2026
The global next-generation cancer therapeutics market size was evaluated at USD 92.54 billion in 2025 and is predicted to hit around USD 186.65 billion by 2035, growing at a CAGR of 7.27%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
July 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
July 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
July 2026
Discover the future of healthcare with digital therapeutics and connected care market empowering patients with smarter, tech-enabled treatment tools.
July 2026
The global mental health digital therapeutics (DTx) market size is growing as digital tools revolutionize mental health treatment through evidence-based software.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The US peptide therapeutics market size was evaluated at USD 21.24 billion in 2025 and is predicted to hit around USD 34.98 billion by 2035, growing at a CAGR of 5.12%.
June 2026
The global brain health supplements and therapeutics market size accounted for USD 18.60 billion in 2025 and is predicted to hit around USD 47.37 billion by 2035, growing at a CAGR of 9.80%.
June 2026
The global alzheimer therapeutics market size is evaluated at USD 6.49 billion in 2025 and is predicted to hit around USD 38.61 billion by 2035, growing at a CAGR of 19.52%.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global rheumatology therapeutics market size is evaluated at USD 51.82 billion in 2025 and is predicted to hit around USD 68.49 billion by 2035, growing at a CAGR of 2.83%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com